New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2014
06:48 EDTNBIXNeurocrine 8M share Secondary priced at $17.75
The deal size was increased to 8M shares from 7M shares. Jefferies and JPMorgan acted as joint book running managers for the offering.
News For NBIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2015
16:11 EDTNBIXNeurocrine reports Q2 EPS (28c), consensus (29c)
Subscribe for More Information
July 27, 2015
10:40 EDTNBIXIsis 'most obvious' Biogen takeover target, TheStreet's Feuerstein says
Subscribe for More Information
July 21, 2015
10:01 EDTNBIXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:09 EDTNBIXNeurocrine resumed with an Outperform at Leerink
Leerink resumed shares of Neurocrine with an Outperform rating and $67 price target. The firm says its survey of 51 physicians who treat Tardive dyskinesia and specialist checks on endometriosis support its view that both NBI-98854 and Elagolix could achieve blockbuster status.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use